Mouse Monoclonal Antibody to Nivolumab (Clone : 8G6G3D8)
Catalogue Number: 45-1086-ABO
| Manufacturer: | Abeomics |
| Type: | Monoclonal Primary Antibody - Unconjugated |
| Shipping Condition: | Blue Ice |
| Unit(s): | 40 ug |
| Host name: | Mouse |
| Clone: | 8G6G3D8 |
| Isotype: | IgG1 |
| Immunogen: | Nivolumab |
| Application: | ELISA |
Description
Description: Nivolumab (Opdivo) is a humanized monoclonal antibody that is approved by the U.S. Food and Drug Administration for the treatment of patients with unresectable or metastatic melanoma. Nivolumab binds to the human cell surface receptor PD-1 (Programmed Cell Death Protein 1) and blocks its interaction with PD-L1, resulting in the activation of T-cell-mediated immune responses against tumor cells. Anti-Nivolumab Antibody (8G6G3D8), mAb, Mouse is produced from a hybridoma resulting from the fusion of partner and B-lymphocytes obtained from a mouse immunized with Nivolumab.
Additional Text
Purification
Protein A purified
Antibody Clonality
Monoclonal
Application Notes
ELISA detection: 0.01-0.1 µg/ml
45-1086 Datasheet
SUPPORT
outstanding technical support
PRODUCT
we offer a full product guarantee
DELIVERY
we offer free delivery to UK universities and non profit organisations